"The
Report Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline
Review, H1 2016 provides information on pricing, market analysis,
shares, forecast, and company profiles for key industry participants.
- MarketResearchReports.biz"
Global Markets Directs, Acute
Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2016,
provides an overview of the Acute Renal Failure (ARF) (Acute Kidney
Injury) pipeline landscape.
The report provides comprehensive
information on the therapeutics under development for Acute Renal
Failure (ARF) (Acute Kidney Injury), complete with analysis by stage
of development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved
in therapeutic development for Acute Renal Failure (ARF) (Acute
Kidney Injury) and features dormant and discontinued projects.
View Report At
http://www.marketresearchreports.biz/analysis/685462
Global Markets Directs report
features investigational drugs from across globe covering over 20
therapy areas and nearly 3,000 indications. The report is built using
data and information sourced from Global Markets Directs proprietary
databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press
releases from company/university sites and industry-specific third
party sources. Drug profiles featured in the report undergoes
periodic review following a stringent set of processes to ensure that
all the profiles are updated with the latest set of information.
Additionally, various dynamic tracking processes ensure that the most
recent developments are captured on a real time basis.
The report helps in identifying
and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective
counter strategies to gain competitive advantage.
Download
Sample copy of this Report at :
http://www.marketresearchreports.biz/sample/sample/685462
Scope
- The report provides a snapshot
of the global therapeutic landscape of Acute Renal Failure (ARF)
(Acute Kidney Injury)
- The report reviews pipeline
therapeutics for Acute Renal Failure (ARF) (Acute Kidney Injury) by
companies and universities/research institutes based on information
derived from company and industry-specific sources
- The report covers pipeline
products based on various stages of development ranging from
pre-registration till discovery and undisclosed stages
- The report features descriptive
drug profiles for the pipeline products which includes, product
description, descriptive MoA, R&D brief, licensing and
collaboration details & other developmental activities
- The report reviews key players
involved Acute Renal Failure (ARF) (Acute Kidney Injury) therapeutics
and enlists all their major and minor projects
- The report assesses Acute Renal
Failure (ARF) (Acute Kidney Injury) therapeutics based on drug
target, mechanism of action (MoA), route of administration (RoA) and
molecule type
- The report summarizes all the
dormant and discontinued pipeline projects
- The report reviews latest news
related to pipeline therapeutics for Acute Renal Failure (ARF) (Acute
Kidney Injury)
Reasons to buy
- Gain strategically significant
competitor information, analysis, and insights to formulate effective
R&D strategies
- Identify emerging players with
potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
- Identify and understand
important and diverse types of therapeutics under development for
Acute Renal Failure (ARF) (Acute Kidney Injury)
- Identify potential new clients
or partners in the target demographic
- Develop strategic initiatives by
understanding the focus areas of leading companies
- Plan mergers and acquisitions
effectively by identifying key players and its most promising
pipeline therapeutics
- Devise corrective measures for
pipeline projects by understanding Acute Renal Failure (ARF) (Acute
Kidney Injury) pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing
and out-licensing strategies by identifying prospective partners with
the most attractive projects to enhance and expand business potential
and scope
- Modify the therapeutic portfolio
by identifying discontinued projects and understanding the factors
that drove them from pipeline
Table
of Contents
Table
of Contents 2
List
of Tables 7
List
of Figures 8
Introduction
9
Global
Markets Direct Report Coverage 9
Acute
Renal Failure (ARF) (Acute Kidney Injury) Overview 10
Therapeutics
Development 11
Pipeline
Products for Acute Renal Failure (ARF) (Acute Kidney Injury) -
Overview 11
Pipeline
Products for Acute Renal Failure (ARF) (Acute Kidney Injury) -
Comparative Analysis 12
Acute
Renal Failure (ARF) (Acute Kidney Injury) - Therapeutics under
Development by Companies 13
Acute
Renal Failure (ARF) (Acute Kidney Injury) - Therapeutics under
Investigation by Universities/Institutes 15
Acute
Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Products Glance
16
Clinical
Stage Products 16
Early
Stage Products 17
Acute
Renal Failure (ARF) (Acute Kidney Injury) - Products under
Development by Companies 18
Acute
Renal Failure (ARF) (Acute Kidney Injury) - Products under
Investigation by Universities/Institutes 20
Acute
Renal Failure (ARF) (Acute Kidney Injury) - Companies Involved in
Therapeutics Development 21
A1M
Pharma AB 21
Adrenomed
AG 22
Am-Pharma
B.V. 23
Angion
Biomedica Corp. 24
Atox
Bio Inc. 25
Cellmid
Limited 26
Complexa,
Inc. 27
DiaMedica
Inc. 28
Digna
Biotech, S.L. 29
DURECT
Corporation 30
F.
Hoffmann-La Roche Ltd. 31
G1
Therapeutics, Inc. 32
Ischemix,
Inc. 33
Kringle
Pharma, Inc. 34
NephroGenex,
Inc. 35
NeuroVive
Pharmaceutical AB 36
Noorik
Biopharmaceuticals AG 37
Noxxon
Pharma AG 38
Nyken
B.V. 39
Orion
Oyj 40
ProMetic
Life Sciences Inc. 41
Quark
Pharmaceuticals, Inc. 42
SBI
Pharmaceuticals Co., Ltd. 43
Spherium
Biomed S.L. 44
STATegics,
Inc. 45
Thrasos
Therapeutics Inc. 46
Torrent
Pharmaceuticals Limited 47
Acute
Renal Failure (ARF) (Acute Kidney Injury) - Therapeutics Assessment
48
Assessment
by Monotherapy Products 48
Assessment
by Combination Products 49
Assessment
by Target 50
Assessment
by Mechanism of Action 52
Assessment
by Route of Administration 54
Assessment
by Molecule Type 56
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment